Publications by authors named "Marcus Thureson"

Claim this Profile
E
Efficacy of melflufen in multiple myeloma with mutated or deleted TP53.
Klara Acs, Juho J Miettinen, Philipp Sergeev, Tobias Heckel, Yumei Diao, Marcus Thureson

Exp Hematol Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Prognostic Value of Pre-Treatment Leukocytosis in Patients with Previously Treated, Stage IIIB/IV Non-Small Cell Lung Cancer Treated with the IGF-1R Pathway Modulator AXL1717 or Docetaxel; a Retrospective Analysis of a Phase II Trial.
Georg Holgersson, Michael Bergqvist, Jonas Nilsson, Marcus Thureson, Johan Harmenberg

Asian Pac J Cancer Prev· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II randomized study of the IGF-1R pathway modulator AXL1717 compared to docetaxel in patients with previously treated, locally advanced or metastatic non-small cell lung cancer.
Michael Bergqvist, Georg Holgersson, Igor Bondarenko, Elena Grechanaya, Alexey Maximovich, Marcus Thureson

Acta Oncol· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis